( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Azhar Sayed Ahmad*, Mohamad Ismaiel and Abdullah Alhkayer


Background: Vitiligo is considered one of the most common disorder of acquired depigmentation, which is associated with significant morbidity. Although several interventions are available, no definite cure has yet been developed. Therefore, alternative treatments have been developed. Aim: The purpose of this study was to evaluate the efficacy of topical latanoprost versus Narrowband Ultraviolet B therapy (NB-UVB) in treatment of vitiligo. Materials and Methods: This was clinical trial (Prospective) involved 80 patients with a diagnosis of stable symmetrical non-segmental vitiligo referred to clinic of dermatology, Tishreen University Hospital, Lattakia, during one-year period (2022-2023). One side of the body was randomly treated with application of latanoprost, while the other side was exposed to NB-UVB and final outcome was compared between two methods. Results: Out of 80 patients, 25 (31.3%) were male and 55 (68.8%) were female, with mean age of the patients was 16.1±7.92 years. Acrofacial (51.3%) and common vitiligo (42.5%) represented the most frequent types of the disease, and the most common sites of vitiligo involvement were face (37.5%) followed by hand and feet (21.3%). Excellent- very good response in repigmentation occurred in 73.8% of the patients in latanoprost group versus 70% in NB-UVB. Regarding of side effects, hair growth on the face was reported in 13.8% of the patients in latanoprost group and first –degree burn in 10% in the other group. Periocular region responded better to treatment than those in other body parts in two groups without any association between improvement and the following variables: gender, family history of vitiligo, duration of disease, and type of disease (p>0.05). Conclusion: The current study showed that latanoprost lead to favorable results in patients with stable non-segmental vitiligo .Except of hair growth on the face after the procedure, significant complications didn’t occur in most patients.

Keywords: latanoprost, Narrowband Ultraviolet B (NB-UVB), outcome, stable, vitiligo.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.


    FEBRUARY 2024 issue has been successfully launched on 1 FEBRUARY 2024.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 February 2024 Issue has been Published, Kindly check it on

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia